SYK and inflammatory response: BALB/c mice treated with GSK143 for 2 weeks after an 8-week HDM-sensitization and challenge protocol were used to evaluate the effect of Syk inhibition in reversing AHR and airway inflammation after establishment of allergic airways inflammation (i.e., in a treatment-based protocol).